Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results

Click here to go back to your search results.

Brain Cancer treatment details. Immunotherapy. Northwestern University, Chicago, IL, United States

Survival: 9.8 months
Toxicity Grade: 5
Treatments: Immunotherapy
Country: United States
City/State/Province: Chicago, IL
Hospital: Northwestern University
Journal: Link
Date: 1/2014

This phase 2 study involved 41 recurrent glioblastoma patients with a median age of 55 years; 73% were male.

Patients were treated with surgery and immunotherapy with the heat shock protein peptide complex-96 (HSPPC-9) vaccine, which can help the immune system target tumor cells.

There was one treatment-related death due to thrombocytopenia and subdural hematoma. Grade 3-4 fatigue, leukopenia, and neurological toxicities were also reported.

The median overall survival was 9.8 months.

Correspondence: Dr. Andrew T. Parsa; email:

E-mail to a Friend Email Physician More Information